Interaction between activated VD3 and Ca channel blockers in patients undergoing hemodialysis

Int J Clin Pharmacol Ther. 2007 Mar;45(3):186-7. doi: 10.5414/cpp45186.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Amlodipine / therapeutic use
  • Antihypertensive Agents / therapeutic use*
  • Blood Pressure / drug effects
  • Calcitriol / therapeutic use*
  • Calcium Channel Blockers / therapeutic use*
  • Cytochrome P-450 CYP3A
  • Cytochrome P-450 Enzyme System / metabolism
  • Drug Interactions
  • Humans
  • Hydroxycholecalciferols / therapeutic use*
  • Nifedipine / therapeutic use
  • Renal Dialysis*

Substances

  • Antihypertensive Agents
  • Calcium Channel Blockers
  • Hydroxycholecalciferols
  • Amlodipine
  • Cytochrome P-450 Enzyme System
  • Cytochrome P-450 CYP3A
  • CYP3A4 protein, human
  • Calcitriol
  • Nifedipine
  • alfacalcidol